The unique N-terminal region of SRMS regulates enzymatic activity and phosphorylation of its novel substrate docking protein 1

FEBS Journal

Volumn 280, Issue 18, 2013, Pages 4539-4559

  Goel, Raghuveera K ^a   Miah, Sayem ^a   Black, Kristin ^a   Kalra, Natasha ^a   Dai, Chenlu ^a   Lukong, Kiven E ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

breast cancer; BRK; Dok1; FRK; SRMS

Indexed keywords

DOCKING PROTEIN; DOCKING PROTEIN 1; PROTEIN SRMS; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHOSPHORYLATION; AUTOREGULATION; BREAST CANCER; CANCER CELL; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

BREAST CANCER; BRK; DOK1; FRK; SRMS;

BREAST NEOPLASMS; CARCINOMA; CELL LINE, TUMOR; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAMMARY GLANDS, HUMAN; MUTATION; NEOPLASM GRADING; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION;

EID: 84883334421     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12420     Document Type: Article

References (60)

1. Robinson DR, Wu YM, &, Lin SF, (2000) The protein tyrosine kinase family of the human genome. Oncogene 19, 5548-5557.
2. Blume-Jensen P, &, Hunter T, (2001) Oncogenic kinase signaling. Nature 411, 355-365.
3. Hanks SK, &, Hunter T, (1995) The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB 9, 576-596.
4. Neet K, &, Hunter T, (1996) Vertebrate non-receptor protein-tyrosine kinase families. Genes Cells 1, 147-169.
5. Serfas MS, &, Tyner AL, (2003) Brk, Srm, Frk, and Src42A form a distinct family of intracellular Src-like tyrosine kinases. Oncol Res 13, 409-419.
6. Kohmura N, Yagi T, Tomooka Y, Oyanagi M, Kominami R, Takeda N, Chiba J, Ikawa Y, &, Aizawa S, (1994) A novel nonreceptor tyrosine kinase, Srm: cloning and targeted disruption. Mol Cell Biol 14, 6915-6925.
7. Kawachi Y, Nakauchi H, &, Otsuka F, (1997) Isolation of a cDNA encoding a tyrosine kinase expressed in murine skin. Exp Dermatol 6, 140-146.
8. Brauer PM, &, Tyner AL, (2010) Building a better understanding of the intracellular tyrosine kinase PTK6-BRK by BRK. Biochim Biophys Acta 1806, 66-73.
9. Llor X, Serfas MS, Bie W, Vasioukhin V, Polonskaia M, Derry J, Abbott CM, &, Tyner AL, (1999) BRK/Sik expression in the gastrointestinal tract and in colon tumors. Clin Cancer Res 5, 1767-1777.
10. Haegebarth A, Bie W, Yang R, Crawford SE, Vasioukhin V, Fuchs E, &, Tyner AL, (2006) Protein tyrosine kinase 6 negatively regulates growth and promotes enterocyte differentiation in the small intestine. Mol Cell Biol 26, 4949-4957.
11. Takeda H, Kawamura Y, Miura A, Mori M, Wakamatsu A, Yamamoto J, Isogai T, Matsumoto M, Nakayama KI, Natsume T, et al,. (2010) Comparative analysis of human SRC-family kinase substrate specificity in vitro. J Proteome Res 9, 5982-5993.
12. Liang X, Wisniewski D, Strife A, Shivakrupa, Clarkson B, &, Resh MD, (2002) Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling. J Biol Chem 277, 13732-13738.
13. Murakami H, Yamamura Y, Shimono Y, Kawai K, Kurokawa K, &, Takahashi M, (2002) Role of Dok1 in cell signaling mediated by RET tyrosine kinase. J Biol Chem 277, 32781-32790.
14. Woodring PJ, Meisenhelder J, Johnson SA, Zhou GL, Field J, Shah K, Bladt F, Pawson T, Niki M, Pandolfi PP, et al,. (2004) c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol 165, 493-503.
15. Niu Y, Roy F, Saltel F, Andrieu-Soler C, Dong W, Chantegrel AL, Accardi R, Thepot A, Foiselle N, Tommasino M, et al,. (2006) A nuclear export signal and phosphorylation regulate Dok1 subcellular localization and functions. Mol Cell Biol 26, 4288-4301.
16. Mashima R, Hishida Y, Tezuka T, &, Yamanashi Y, (2009) The roles of Dok family adapters in immunoreceptor signaling. Immunol Rev 232, 273-285.
17. Brauer PM, &, Tyner AL, (2009) RAKing in AKT: a tumor suppressor function for the intracellular tyrosine kinase FRK. Cell Cycle 8, 2728-2732.
18. Mitchell PJ, Barker KT, Martindale JE, Kamalati T, Lowe PN, Page MJ, Gusterson BA, &, Crompton MR, (1994) Cloning and characterisation of cDNAs encoding a novel non-receptor tyrosine kinase, brk, expressed in human breast tumours. Oncogene 9, 2383-2390.
19. Ostrander JH, Daniel AR, Lofgren K, Kleer CG, &, Lange CA, (2007) Breast tumor kinase (protein tyrosine kinase 6) regulates heregulin-induced activation of ERK5 and p38 MAP kinases in breast cancer cells. Cancer Res 67, 4199-4209.
20. Miah S, Martin L, &, Lukong KE, (2012) Constitutive activation of breast tumor kinase accelerates cell migration and tumor growth in vivo. Oncogenesis 1, e11.
21. Qiu H, &, Miller WT, (2002) Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition. J Biol Chem 277, 34634-34641.
22. Qiu H, &, Miller WT, (2004) Role of the Brk SH3 domain in substrate recognition. Oncogene 23, 2216-2223.
23. Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A, &, Kuriyan J, (1999) Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol Cell 3, 639-648.
24. Okada M, (2012) Regulation of the SRC family kinases by Csk. Int J Biol Sci 8, 1385-1397.
25. LaFevre-Bernt M, Sicheri F, Pico A, Porter M, Kuriyan J, &, Miller WT, (1998) Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue. J Biol Chem 273, 32129-32134.
26. Waksman G, Kominos D, Robertson SC, Pant N, Baltimore D, Birge RB, Cowburn D, Hanafusa H, Mayer BJ, Overduin M, et al,. (1992) Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653.
27. Bibbins KB, Boeuf H, &, Varmus HE, (1993) Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides. Mol Cell Biol 13, 7278-7287.
28. Mitchell PJ, Sara EA, &, Crompton MR, (2000) A novel adaptor-like protein which is a substrate for the non-receptor tyrosine kinase, BRK. Oncogene 19, 4273-4282.
29. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, &, Clarkson B, (1997) p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88, 197-204.
30. Gerard A, Favre C, Garcon F, Nemorin JG, Duplay P, Pastor S, Collette Y, Olive D, &, Nunes JA, (2004) Functional interaction of RasGAP-binding proteins Dok-1 and Dok-2 with the Tec protein tyrosine kinase. Oncogene 23, 1594-1598.
31. Di Cristofano A, Niki M, Zhao M, Karnell FG, Clarkson B, Pear WS, Van Aelst L, &, Pandolfi PP, (2001) p62(dok), a negative regulator of Ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210(bcr-abl). J Exp Med 194, 275-284.
32. Yasuda T, Shirakata M, Iwama A, Ishii A, Ebihara Y, Osawa M, Honda K, Shinohara H, Sudo K, Tsuji K, et al,. (2004) Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia. J Exp Med 200, 1681-1687.
33. Inaba T, Oku N, Gotoh H, Murakami S, Itoh K, Ura Y, Nakanishi S, Shimazaki C, Nakagawa M, et al,. (1991) Philadelphia chromosome positive precursor B-cell acute lymphoblastic leukemia with a translocation t(2;14)(p13;q32). Leukemia 5, 719-722.
34. Saulnier A, Vaissiere T, Yue J, Siouda M, Malfroy M, Accardi R, Creveaux M, Sebastian S, Shahzad N, Gheit T, et al,. (2012) Inactivation of the putative suppressor gene DOK1 by promoter hypermethylation in primary human cancers. Int J Cancer J Int du Cancer 130, 2484-2494.
35. Lee S, Roy F, Galmarini CM, Accardi R, Michelon J, Viller A, Cros E, Dumontet C, &, Sylla BS, (2004) Frameshift mutation in the Dok1 gene in chronic lymphocytic leukemia. Oncogene 23, 2287-2297.
36. Harvey AJ, &, Crompton MR, (2004) The Brk protein tyrosine kinase as a therapeutic target in cancer: opportunities and challenges. Anticancer Drugs 15, 107-111.
37. Easty DJ, Mitchell PJ, Patel K, Flørenes VA, Spritz RA, &, Bennett DC, (1997) Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int J Cancer 71, 1061-1065.
38. Petro BJ, Tan RC, Tyner AL, Lingen MW, &, Watanabe K, (2004) Differential expression of the non-receptor tyrosine kinase BRK in oral squamous cell carcinoma and normal oral epithelium. Oral Oncol 40, 1040-1047.
39. Derry JJ, Prins GS, Ray V, &, Tyner AL, (2003) Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells. Oncogene 22, 4212-4220.
40. Kasprzycka M, Majewski M, Wang ZJ, Ptasznik A, Wysocka M, Zhang Q, Marzec M, Gimotty P, Crompton MR, &, Wasik MA, (2006) Expression and oncogenic role of Brk (PTK6/Sik) protein tyrosine kinase in lymphocytes. Am J Pathol 168, 1631-1641.
41. Schmandt RE, Bennett M, Clifford S, Thornton A, Jiang F, Broaddus RR, Sun CC, Lu KH, Sood AK, &, Gershenson DM, (2006) The BRK tyrosine kinase is expressed in high-grade serous carcinoma of the ovary. Cancer Biol Ther 5, 1136-1141.
42. Kamalati T, Jolin HE, Fry MJ, &, Crompton MR, (2000) Expression of the BRK tyrosine kinase in mammary epithelian cells enhances the coupling of EGF signalling to PI 3-kinase and Akt, via erbB3 phosphorylation. Oncogene 19, 5471-5476.
43. Kamalati T, Jolin HE, Mitchell PJ, Barker KT, Jackson LE, Dean CJ, Page MJ, Gusterson BA, &, Crompton MR, (1996) Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor. J Biol Chem 271, 30956-30963.
44. Meyer T, Xu L, Chang J, Liu ET, Craven RJ, &, Cance WG, (2003) Breast cancer cell line proliferation blocked by the Src-related Rak tyrosine kinase. Int J Cancer 104, 139-146.
45. Yim EK, Peng G, Dai H, Hu R, Li K, Lu Y, Mills GB, Meric-Bernstam F, Hennessy BT, Craven RJ, et al,. (2009) Rak functions as a tumor suppressor by regulating PTEN protein stability and function. Cancer Cell 15, 304-314.
46. Sheng ZM, Marchetti A, Buttitta F, Champeme MH, Campani D, Bistocchi M, Lidereau R, &, Callahan R, (1996) Multiple regions of chromosome 6q affected by loss of heterozygosity in primary human breast carcinomas. Br J Cancer 73, 144-147.
47. Becher R, Gibas Z, &, Sandberg AA, (1983) Chromosome 6 in malignant melanoma. Cancer Genet Cytogenet 9, 173-175.
48. Mayer BJ, Hirai H, &, Sakai R, (1995) Evidence that Sh2 domains promote processive phosphorylation by protein-tyrosine kinases. Curr Biol 5, 296-305.
49. Ie Kim H, &, Lee ST, (2009) Oncogenic functions of PTK6 are enhanced by its targeting to plasma membrane but abolished by its targeting to nucleus. J Biochem 146, 133-139.
50. Derry JJ, Richard S, Carvajal HV, Ye X, Vasioukhin V, Cochrane AW, Chen T, &, Tyner AL, (2000) Sik (BRK) phosphorylates Sam68 in the nucleus and negatively regulates its RNA binding activity. Mol Cell Biol 20, 6114-6126.
51. Okada M, &, Nakagawa H, (1989) A protein tyrosine kinase involved in regulation of pp 60c-src function. J Biol Chem 264, 20886-20893.
52. Pluk H, Dorey K, &, Superti-Furga G, (2002) Autoinhibition of c-Abl. Cell 108, 247-259.
53. Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, Bornmann W, Clarkson B, Superti-Furga G, &, Kuriyan J, (2003) Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112, 859-871.
54. Sicheri F, Moarefi I, &, Kuriyan J, (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385, 602-609.
55. McPherson RA, Taylor MM, Hershey ED, &, Sturgill TW, (2000) A different function for a critical tryptophan in c-Raf and Hck. Oncogene 19, 3616-3622.
56. Mercier PL, Bachvarova M, Plante M, Gregoire J, Renaud MC, Ghani K, Tetu B, Bairati I, &, Bachvarov D, (2011) Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol 5, 438-453.
57. Cong F, Yuan B, &, Goff SP, (1999) Characterization of a novel member of the DOK family that binds and modulates Abl signaling. Mol Cell Biol 19, 8314-8325.
58. Noguchi T, Matozaki T, Inagaki K, Tsuda M, Fukunaga K, Kitamura Y, Kitamura T, Shii K, Yamanashi Y, &, Kasuga M, (1999) Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration. EMBO J 18, 1748-1760.
59. Chen T, Boisvert FM, Bazett-Jones DP, &, Richard S, (1999) A role for the GSG domain in localizing Sam68 to novel nuclear structures in cancer cell lines. Mol Biol Cell 10, 3015-3033.
60. Lukong KE, Huot ME, &, Richard S, (2009) BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest. Cell Signal 21, 1415-1422.